GOOGL
47
4
CAT
58
-8
LYB
22
2
KIM
50
-3
BMY
76
2
HCA
64
5
FSLR
73
15
REGN
59
2
GILD
56
6
QCOM
45
2
DTE
38
-4
KSS
62
3
RCL
68
4
ADT
50
2
SPG
48
2
AVY
47
-7
KMB
31
-11
IR
58
3
WFC
74
5
ALLE
44
3
GOOGL
47
4
CAT
58
-8
LYB
22
2
KIM
50
-3
BMY
76
2
HCA
64
5
FSLR
73
15
REGN
59
2
GILD
56
6
QCOM
45
2
DTE
38
-4
KSS
62
3
RCL
68
4
ADT
50
2
SPG
48
2
AVY
47
-7
KMB
31
-11
IR
58
3
WFC
74
5
ALLE
44
3
Financhill
Back

Vanguard S&P Mid-Cap 400 Value Index Fund ETF Vs. Monopar Therapeutics, Inc. Industry Stock Comparison

Buy
75

IVOV
Vanguard S&P Mid-Cap 400 Value Index Fund ETF

Last Price:
$104.11
Seasonality Move:
4.79%
Sell
34

MNPR
Monopar Therapeutics, Inc.

Last Price:
$69.11
Seasonality Move:
25.93%
Buy
75
Vanguard S&P Mid-Cap 400 Value Index Fund ETF (IVOV) is a Buy

Is Vanguard S&P Mid-Cap 400 Value Index Fund ETF a Buy, Sell or Hold?

  • The current Vanguard S&P Mid-Cap 400 Value Index Fund ETF [IVOV] share price is $104.16. The Score for IVOV is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
  • IVOV is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
34
Monopar Therapeutics, Inc. (MNPR) is a Sell

Is Monopar Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Monopar Therapeutics, Inc. [MNPR] share price is $68.63. The Score for MNPR is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • MNPR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

IVOV Stock Price Chart

What is Vanguard S&P Mid-Cap 400 Value Index Fund ETF's stock price today?

  • The Vanguard S&P Mid-Cap 400 Value Index Fund ETF share price today is $104.16
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IVOV is experiencing buying pressure, which is a positive indicator for future bullish movement.

MNPR Stock Price Chart

What is Monopar Therapeutics, Inc.'s stock price today?

  • The Monopar Therapeutics, Inc. share price today is $68.63
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing slight buying pressure.

IVOV Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.07 Buy
Relative Strength Index (14 RSI): 60.91 Buy
Chaikin Money Flow: 7215 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (99.04 - 104.2) Buy
Bollinger Bands (100): (98 - 102.42) Buy

MNPR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.61 Sell
Relative Strength Index (14 RSI): 37.25 Sell
Chaikin Money Flow: 166161 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (72.18 - 85.74) Sell
Bollinger Bands (100): (45.57 - 89.21) Buy

IVOV Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 104.14 Buy
20-day SMA: 102.69 Buy
50-day SMA: 100.74 Buy
200-day SMA: 96.35 Buy
8-day EMA: 103.7 Buy
20-day EMA: 102.7 Buy
50-day EMA: 101.35 Buy
200-day EMA: 98.1 Buy

MNPR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 72.35 Sell
20-day SMA: 78.65 Sell
50-day SMA: 81.47 Sell
200-day SMA: 52.32 Buy
8-day EMA: 71.44 Sell
20-day EMA: 75.9 Sell
50-day EMA: 76.79 Sell
200-day EMA: 56.68 Buy

Vanguard S&P Mid-Cap 400 Value Index Fund ETF Earnings Growth & IVOV Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Monopar Therapeutics, Inc. Earnings Growth & MNPR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $1.78 per share.

Vanguard S&P Mid-Cap 400 Value Index Fund ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Monopar Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):